Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in Beijing, China

被引:0
|
作者
Tian, Di [1 ]
Pan, Yang [2 ]
Ge, Ziruo [1 ]
Kong, Xiangjing [1 ]
Zhang, Yao [1 ]
Zhang, Qing [1 ]
Wang, Aibin [1 ]
Yang, Peng [2 ]
Chen, Zhihai [1 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Emergency Dept COVID 19, Beijing 100015, Peoples R China
[2] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing 100013, Peoples R China
来源
INFECTIOUS DISEASES & IMMUNITY | 2023年 / 3卷 / 02期
关键词
SARS-CoV-2; Delta variant; Omicron variant; Clinical characteristics;
D O I
10.1097/ID9.0000000000000081
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Delta and Omicron are two main variants that have been prevalent since 2021. However, the Omicron variant of severe acute respiratory syndrome coronavirus 2 shows a less severe clinical presentation and high transmissibility. Therefore, we carried out this retrospective study to evaluate Omicron severity compared with the Delta variant and further comprehend the differences in clinical characteristics in patients with the Omicron variant. Methods: We extracted clinical data and compared clinical severity, symptoms, vaccination status, laboratory parameters, viral shedding time, and computed tomography (CT) imaging between the two groups of patients, which included 109 COVID-19 cases with the Delta variant and 183 cases with the Omicron variant, from January 19 to April 1, 2022, in Beijing Ditan Hospital. In addition, the Beijing Center for Disease Prevention and Control conducted whole-genome sequencing. Results: We obtained 94 strains of variants of concern/Delta and 110 strains of variants of concern/Omicron. For the 110 Omicron strains, three were assigned as BA.1.1, 53 as BA.2, and 54 as BA.2.2. Among patients with the Delta variant, 54% (59/109) were moderate, which was significantly higher than that of patients with the Omicron variant (7% (12/183), P < 0.001). The number of patients with mild symptoms in the Omicron group was significantly higher than in the Delta group (80% vs. 35%, P < 0.001). Compared with the Omicron group, patients with underlying diseases or obesity, 60 years or older, or unvaccinated in the Delta group had more severe disease, and there was a significant difference between the two groups. The viral shedding time in the Omicron group was shorter than in the Delta group ((11.9 +/- 5.9) vs. (14.0 +/- 5.8) days, P = 0.003). Among the 183 patients in the Omicron group, 104 (57%) had dry or sore throat symptoms, more than those in the Delta group (34% (37/109); P < 0.001). In the Delta group, patients in the moderate group had more fever and cough symptoms than those in the mild group. The remission time of CT imaging in the Omicron group was shorter than in the Delta group ((9.0 +/- 5.2) vs. (13.2 +/- 4.2) days, P = 0.018). Conclusions: Patients with Delta variants are more likely to have pneumonia, mainly with fever and cough symptoms, while patients with the Omicron variant are mostly mild, with more prominent dry or sore throat symptoms. In addition, patients with the Omicron variant have a short viral shedding time and rapid absorption of pneumonia.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [31] Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients
    Liu Lina
    Guo Zhendong
    Sevalie, Stephen
    Zhang Fangfang
    Zhang Dawei
    Chen Weiwei
    Li Xiao
    Zhao Zongzheng
    JOURNAL OF INFECTION, 2022, 85 (05) : 576 - 577
  • [32] Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
    Norddahl, Gudmundur L.
    Melsted, Pall
    Gunnarsdottir, Kristbjorg
    Halldorsson, Gisli H.
    Olafsdottir, Thorunn A.
    Gylfason, Arnaldur
    Kristjansson, Mar
    Magnusson, Olafur T.
    Sulem, Patrick
    Gudbjartsson, Daniel F.
    Thorsteinsdottir, Unnur
    Jonsdottir, Ingileif
    Stefansson, Kari
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [33] Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature
    Pottage, Thomas
    Onianwa, Okechukwu
    Atkinson, Barry
    Spencer, Antony
    Bennett, Allan M.
    VIROLOGY, 2023, 583 : 27 - 28
  • [34] The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
    Chavda, Vivek P.
    Bezbaruah, Rajashri
    Deka, Kangkan
    Nongrang, Lawandashisha
    Kalita, Tutumoni
    VACCINES, 2022, 10 (11)
  • [35] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
    Hanjun Zhao
    Kelvin Kai-Wang To
    Hoiyan Lam
    Chuyuan Zhang
    Zheng Peng
    Xinjie Meng
    Xiankun Wang
    Anna Jinxia Zhang
    Bingpeng Yan
    Jianpiao Cai
    Man Lung Yeung
    Jasper Fuk-Woo Chan
    Kwok-Yung Yuen
    Cell Discovery, 8
  • [36] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836
  • [37] Understanding the mechanisms of increased pathogenicity and virulence of SARS-CoV-2 Delta and Omicron variants
    Dutta, Mandira
    Voth, Gregory A.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 136A - 136A
  • [38] Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
    Kim, A. Reum
    Lee, Jiyoung
    Park, Somi
    Kang, Sung Woon
    Lee, Yun Woo
    Lim, So Yun
    Chang, Euijin
    Bae, Seongman
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Kim, Sung-Han
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (01) : 133 - 135
  • [39] Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
    Gudmundur L. Norddahl
    Pall Melsted
    Kristbjorg Gunnarsdottir
    Gisli H. Halldorsson
    Thorunn A. Olafsdottir
    Arnaldur Gylfason
    Mar Kristjansson
    Olafur T. Magnusson
    Patrick Sulem
    Daniel F. Gudbjartsson
    Unnur Thorsteinsdottir
    Ingileif Jonsdottir
    Kari Stefansson
    Nature Communications, 13
  • [40] Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants
    Rao, Anuradha
    Westbrook, Adrianna
    Bassit, Leda
    Parsons, Richard
    Fitts, Eric
    Greenleaf, Morgan
    McLendon, Kaleb
    Sullivan, Julie A.
    O'Sick, William
    Baugh, Tyler
    Bowers, Heather B.
    Frank, Filipp
    Wang, Ethan
    Le, Mimi
    Frediani, Jennifer
    Roychoudhury, Pavitra
    Greninger, Alexander L.
    Jerris, Robert
    Pollock, Nira R.
    Ortlund, Eric A.
    Roback, John D.
    Lam, Wilbur A.
    Piantadosi, Anne
    JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (10)